Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nasimudeen R. Jabir, Khalid Anwar, Chelapram K. Firoz, Mohammad Oves, Mohammad Amjad Kamal & Shams Tabrez. (2018) An overview on the current status of cancer nanomedicines. Current Medical Research and Opinion 34:5, pages 911-921.
Read now
Read now
Jane E Rogers. (2017) Patient considerations in metastatic colorectal cancer – role of panitumumab. OncoTargets and Therapy 10, pages 2033-2044.
Read now
Read now
Louisa Lo, Dainik Patel, Amanda R Townsend & Timothy J Price. (2015) Pharmacokinetic and pharmacodynamic evaluation of panitumumab in the treatment of colorectal cancer. Expert Opinion on Drug Metabolism & Toxicology 11:12, pages 1907-1924.
Read now
Read now
Jason M. Warram, Esther de Boer, Melissa Korb, Yolanda Hartman, Joy Kovar, James M. Markert, G. Yancey Gillespie & Eben L. Rosenthal. (2015) Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. British Journal of Neurosurgery 29:6, pages 850-858.
Read now
Read now
Gorjan Hrustanovic, Bianca J. Lee & Trever G. Bivona. (2013) Mechanisms of resistance to EGFR targeted therapies. Cancer Biology & Therapy 14:4, pages 304-314.
Read now
Read now
Articles from other publishers (5)
Gretchen Bergado-Báez, Narjara Gonzalez Suarez, Lisset Chao García, Dayana Pérez-Martínez, Diana Rosa Hernández-Fernández, Talia Fundora-Barrios, Antonio Rodríguez-Álvarez, Geidy Diana Díaz-Ordaz, Moshit Lindzen, Yosef Yarden & Belinda Sánchez-Ramírez. (2022) Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies. Frontiers in Oncology 12.
Crossref
Crossref
Ryuhei Okada, Takuya Kato, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Daiki Fujimura, Shuhei Okuyama, Hideyuki Furumoto, Hiroshi Fukushima, Peter L. Choyke & Hisataka Kobayashi. (2022) Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy. Cancer Immunology, Immunotherapy 71:8, pages 1877-1887.
Crossref
Crossref
Jesús García-Foncillas, Yu Sunakawa, Dan Aderka, Zev Wainberg, Philippe Ronga, Pauline Witzler & Sebastian Stintzing. (2019) Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors. Frontiers in Oncology 9.
Crossref
Crossref
Sadaf Aghevlian, Yijie Lu, Mitchell A. Winnik, David W. Hedley & Raymond M. Reilly. (2018)
Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
111
In and
177
Lu—An EGFR-Targeted Theranostic for Pancreatic Cancer
. Molecular Pharmaceutics 15:3, pages 1150-1159.
Crossref
Crossref
Judith Niesen, Markus Sack, Melanie Seidel, Rolf Fendel, Stefan Barth, Rainer Fischer & Christoph Stein. (2016) SNAP-Tag Technology: A Useful Tool To Determine Affinity Constants and Other Functional Parameters of Novel Antibody Fragments. Bioconjugate Chemistry 27:8, pages 1931-1941.
Crossref
Crossref